Poor-grade aneurysmal subarachnoid hemorrhage (aSAH) represents one of the most demanding scenarios in neurosurgery and neurocritical care. While modern medical advances have improved survival for many, patients presenting with World Federation of Neurosurgical Societies (WFNS) grades IV and V still face daunting odds. Understanding poor-grade aSAH outcomes is therefore vital for clinicians aiming to refine management protocols and improve patient prognosis.

Recent Multicenter Findings on Poor-Grade aSAH Outcomes

A significant multicenter study conducted across northern China recently provided new insights into these challenges. Researchers followed 1,339 patients for an average of 26 months. This extensive follow-up revealed a high long-term mortality rate of 51.1%. Furthermore, approximately 21.4% of the survivors remained dependent. These figures highlight the persistent severity of the condition, even with current intensive care standards.

The research identified several critical risk factors for mortality. Specifically, patients aged 65 years or older and those with a history of stroke faced higher risks. Additionally, a WFNS grade of V significantly worsened the prognosis. Conversely, the study noted that endovascular treatment served as a protective factor compared to traditional surgical methods. However, conservative management without active aneurysm repair led to the poorest results.

Independent Drivers of Long-Term Dependency

Functional recovery is just as important as survival in clinical practice. The study found that WFNS grade V and the presence of middle cerebral artery aneurysms were independent risk factors for dependency. Consequently, healthcare providers must consider these anatomical and clinical markers when counseling families about long-term expectations. Active intervention remains crucial, as the data strongly suggests that avoiding treatment significantly increases the likelihood of death or permanent disability.

Furthermore, while mortality has trended downward in recent years, the clinical burden remains substantial. Clinicians should prioritize early stabilization and definitive aneurysm treatment whenever possible. This proactive approach offers the best chance to mitigate the high risks associated with these severe neurological events. Therefore, a multidisciplinary strategy involving neurosurgeons, neurologists, and intensivists is essential for optimizing care.

FAQs

What are the primary risk factors for mortality in poor-grade aSAH?

The main risk factors for mortality include advanced age (65 years or older), a previous history of stroke, and a WFNS grade of V upon admission.

How does endovascular treatment compare to surgical treatment for poor-grade aSAH?

The study indicates that endovascular treatment may act as a protective factor compared to surgical treatment, although both are far superior to conservative management for improving long-term survival.

Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.

References

1. Wang B et al. Long-term outcomes of poor-grade aneurysmal subarachnoid hemorrhage: a multicenter observational cohort study. J Neurosurg. 2026 Feb 13. doi: 10.3171/2025.10.JNS25978. PMID: 41687104.


2. An X et al. Comparison of microsurgical and endovascular treatment outcomes in poor-grade aneurysmal subarachnoid hemorrhage: a multicenter cohort study. Neurosurg Rev. 2026 Feb 9;49(1):210. doi: 10.1007/s10143-026-04167-3.


3. Giri PJ et al. The clinical profile, management, and overall outcome of aneurysmal subarachnoid hemorrhage at the neurosurgical unit of a tertiary care center in India. J Neurosci Rural Pract. 2022.